权威例句
Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulatorCDB-2914 for uterine leiomyomata treatment: a randomized controlled trialCDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity:...Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regul...Pharmacologic properties of CDB(VA)-2914Development of the selective progesterone receptor modulator CDB-2914 for clinical indicationsCDB Lecture: From nerve growth to synapse formation and plasticityStudy on Source Correction of CDB SpectroscopyMixed layer depth over the global ocean: An examination of profile data and a profile‐based climatologyImmunosuppression: practice and trends